BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37406762)

  • 1. Clostridioides difficile PCR Tcdb Cycle Threshold predicts toxin EIA positivity but not severity of infection.
    Mah R; Locher K; Steiner TS; Stefanovic A
    Anaerobe; 2023 Aug; 82():102755. PubMed ID: 37406762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples.
    Cho DH; Kim SH; Jeon CH; Kim HT; Park KJ; Kim J; Kwak J; Kwan BS; Kong S; Lee JW; Kim KM; Wi YM
    Ann Clin Microbiol Antimicrob; 2024 Apr; 23(1):35. PubMed ID: 38664689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
    Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
    J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxin positivity and tcdB gene load in broad-spectrum Clostridium difficile infection.
    Kim HN; Kim H; Moon HW; Hur M; Yun YM
    Infection; 2018 Feb; 46(1):113-117. PubMed ID: 29218569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxin B PCR Amplification Cycle Threshold Adds Little to Clinical Variables for Predicting Outcomes in
    Origüen J; Orellana MÁ; Fernández-Ruiz M; Corbella L; San Juan R; Ruiz-Ruigómez M; López-Medrano F; Lizasoain M; Ruiz-Merlo T; Maestro-de la Calle G; Parra P; Villa J; Delgado R; Aguado JM
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan.
    Chang FC; Liu CP; Sun FJ; Lin CC
    J Microbiol Immunol Infect; 2021 Apr; 54(2):284-289. PubMed ID: 31624018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can a toxin gene NAAT be used to predict toxin EIA and the severity of
    Garvey MI; Bradley CW; Wilkinson MAC; Holden E
    Antimicrob Resist Infect Control; 2017; 6():127. PubMed ID: 29270290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience.
    Menon A; Perry DA; Motyka J; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
    Clin Infect Dis; 2021 Nov; 73(9):e2883-e2889. PubMed ID: 32930705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
    Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
    Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent Class Analysis for the Diagnosis of Clostridioides difficile Infection.
    Doolan CP; Louie T; Lata C; Larios OE; Stokes W; Kim J; Brown K; Beck P; Deardon R; Pillai DR
    Clin Infect Dis; 2021 Nov; 73(9):e2673-e2679. PubMed ID: 33053174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of toxin B and binary toxin in
    López-Cárdenas S; Torres-Martos E; Mora-Delgado J; Sánchez-Calvo JM; Santos-Peña M; Zapata López Á; Dolores López-Prieto M; Pérez-Cortés S; Carlos Alados J
    Gut Microbes; 2021; 13(1):1884516. PubMed ID: 33660568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM; Uslan DZ; Rubin Z
    J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients.
    Toltzis P; Nerandzic MM; Saade E; O'Riordan MA; Smathers S; Zaoutis T; Kim J; Donskey CJ
    Infect Control Hosp Epidemiol; 2012 Feb; 33(2):175-9. PubMed ID: 22227987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.
    Shin BM; Kuak EY; Lee EJ; Songer JG
    J Clin Microbiol; 2009 Sep; 47(9):2952-6. PubMed ID: 19625481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory diagnosis of Clostridioides difficile infection in symptomatic patients: what can we do better?
    Maestri AC; Nogueira KS; Mialski R; Dos Santos EM; Kraft L; Raboni SM
    Braz J Microbiol; 2023 Jun; 54(2):849-857. PubMed ID: 36991280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile.
    Larson AM; Fung AM; Fang FC
    J Clin Microbiol; 2010 Jan; 48(1):124-30. PubMed ID: 19923482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of a newly developed high-speed polymerase chain reaction analysis system for the diagnosis of Clostridioides difficile infection.
    Furukawa K; Mitsutake H; Aso R; Sekizawa R; Okanda T; Hayashi K; Matsumoto T; Nakamura S
    J Infect Chemother; 2021 May; 27(5):715-721. PubMed ID: 33402305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and clinical application of a rapid, visually interpretable polymerase spiral reaction for tcdB gene of Clostridioides difficile in fecal cultures.
    Yin C; Song Z; Wang X; Li H; Liu Y; Wang Q; Feng X; Song X
    FEMS Microbiol Lett; 2023 Jan; 370():. PubMed ID: 37537148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.